Field-Ready RT-LAMP Brings Influenza D Virus Detection Closer to the Barn
Influenza D virus is no longer a virologic curiosity confined to niche surveillance reports. The virus has established itself primarily in cattle and swine, with evidence of cross-species transmission and a growing body of serologic data suggesting repeated human exposure in occupational settings. Against that backdrop, a rapid molecular assay with field usability carries obvious practical value, especially where conventional laboratory infrastructure is thin or absent.
The new reverse transcription loop-mediated isothermal amplification assay was built for exactly that gap. It targets influenza D virus RNA in a format that can be run at a constant temperature, returns results in under an hour, and avoids the logistical burden of quantitative reverse transcription PCR. In settings where animal respiratory disease needs to be triaged quickly, speed is not just convenience; it can determine whether surveillance keeps pace with circulation.
Why Influenza D Virus Demands Better Surveillance Tools
Influenza D virus belongs to the Orthomyxoviridae family and was first identified in pigs in Oklahoma in 2011 before cattle emerged as the main livestock reservoir. In cattle, infection is associated with bovine respiratory disease and may help open the door to secondary bacterial infection, a familiar pathway in mixed respiratory syndromes where viral injury disrupts mucosal defenses. The same receptor biology that supports infection in cattle, pigs, sheep, goats, and horses also explains why the host range appears wider than the earliest reports implied: the virus binds 9-O-acetylated sialic acid receptors found in the respiratory tract of several species.
Human infection remains unconfirmed, but the serology is hard to ignore. Antibodies have been documented in the general population in North America, and higher seroprevalence has been seen in Italy over time, while occupationally exposed cattle workers have shown very high rates of exposure. Molecular detection still matters because antibodies can only tell us about past contact, not active infection. Viral RNA detection is the sharper tool for identifying current circulation, and that is the niche this assay is designed to fill.
A single positive animal can matter when transmission is silent.
Primer Design Focused on Conservation and Specificity
The assay was designed against the two most conserved influenza D genes, PB1 and PB2, using downloaded sequence data, multiple sequence alignment, and LAMP primer design software. The design strategy prioritized breadth without sacrificing specificity. A consensus threshold of 90% was used, mutated sites were manually reviewed, and primer candidates were filtered for end stability and secondary-structure problems such as hairpins, self-dimers, and homodimers.
That attention to structure is not a cosmetic detail. LAMP works by building a growing concatemer with loop structures that sustain continuous amplification, so primer performance depends heavily on local thermodynamics and sequence compatibility. T linkers were inserted between the F1c/F2 and B1c/B2 regions to reduce local melting temperature in the loops and limit the formation of secondary structures that could slow the reaction. The primer sets were also checked against other influenza viruses to confirm specificity for influenza D.
The result was a colorimetric one-step assay that can be run in a 20 μL reaction volume with a WarmStart LAMP master mix, a primer mix containing F3/B3, FIP/BIP, and LF/LB, and either fluorescence-based or colorimetric readout. The workflow was tested at 65°C, the constant-temperature environment that makes RT-LAMP attractive in resource-limited settings.
Performance Across Spiked Samples and Clinical Isolates
Evaluation included 28 experimentally spiked samples and 46 isolated RNA samples from swine and cattle, including nasal swabs and respiratory tissues from animals with cough or dyspnea submitted through passive surveillance networks. The testing panel also included well-characterized virus isolates, among them D/swine/Oklahoma/1334/2011, D/bovine/France/5920/2014, and the more recent D/swine/England/126471/2023. Positive and negative controls were extracted with every batch, and qRT-PCR was used to verify extraction efficiency and guard against cross-contamination.
Specificity reached 99.2%. Sensitivity ranged from 95.6% when cycle quantification was below 30 to 81.8% when cycle quantification was below 40. Those numbers place the assay in a useful operational range for field work, where the main question is often whether a sample with meaningful viral burden can be identified rapidly enough to guide next steps. The assay was also challenged against closely related influenza virus targets and remained focused on influenza D rather than broadly amplifying other influenza genomes.
In practice, that means the assay is most powerful where it is needed most: early triage, outbreak screening, and surveillance in animal populations where laboratory transport can delay interpretation. A test that can be deployed outside a central laboratory changes what surveillance can look like on the ground.
What the Data Mean for Veterinary and Zoonotic Surveillance
Influenza D sits in an awkward and increasingly important space. It is clearly established in livestock, has serologic evidence of repeated human exposure, and shares enough biological features with other influenza viruses to justify close monitoring, yet active human infection has not been confirmed. That combination creates a surveillance problem with no easy shortcut. qRT-PCR remains the standard for individual-level RNA detection, but it is expensive, infrastructure-dependent, and less practical for high-throughput or point-of-sample use.
RT-LAMP offers a more accessible route. It is faster, can be run without cycling equipment, and is well suited to low-resource settings where animal samples are collected far from sophisticated molecular laboratories. During the COVID-19 pandemic, the broader adoption of RT-LAMP demonstrated that isothermal amplification can be more than an emergency substitute; it can be a durable operational tool when speed and simplicity matter. For influenza D, the same logic applies in veterinary surveillance, where respiratory disease in herds can spread before conventional systems have time to react.
The biological rationale is straightforward. Influenza viruses evolve, cross species barriers, and adapt to new hosts with a flexibility that punishes slow detection systems. By preserving specificity for influenza D while keeping the assay practical for field deployment, this RT-LAMP platform gives surveillance teams a way to look earlier and more often.
Remaining Gaps in Real-World Deployment
The validation set was focused on experimentally spiked material and isolated RNA from swine and cattle, so broader deployment will still need to show how the assay performs across routine field conditions, diverse sample quality, and larger surveillance networks. The assay’s strongest sensitivity was observed at lower cycle quantification values, which means viral burden will still shape detection success. Diagnostic performance outside the controlled study environment will depend on how consistently sample collection, extraction, and reaction setup can be maintained.
Even so, the core finding is hard to dismiss: a rapid, cost-conscious RT-LAMP assay can detect influenza D virus with high specificity and strong sensitivity in the range most relevant to practical surveillance. In a pathogen that may already be more widespread than active case finding suggests, the ability to test quickly at the point of need is a meaningful advance in how veterinary and zoonotic monitoring can be organized.